AGEING RESEARCH REVIEWS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=895544, encodeId=5eea895544d8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80cf2053027, createdName=傲娇的小马尾, createdTime=Thu Oct 29 23:45:50 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215141, encodeId=5f69121514112, content=4.21投稿，4.27还在submitted to journal的状态，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbd32341984, createdName=122921ecm60(暂无昵称), createdTime=Wed Apr 27 21:45:28 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161347, encodeId=d1ad216134ea4, content=投稿命中率:25.0 经验分享：with editor时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Sat Oct 07 15:07:56 CST 2023, time=2023-10-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1235154, encodeId=8f7b12351542a, content=2022.7.14 投稿 7.18 With editor 7.20 开始Under Review 7.25两个审稿人接收审稿 保佑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=小田田19921106, createdTime=Wed Jul 27 21:31:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248959, encodeId=5e8e124895971, content=with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Wed Sep 14 21:55:23 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157856, encodeId=0391215e85664, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：衰老;神经退行性疾病 经验分享：6.9投，8.27一审小修，9.6投回，9.9收。我们实验室中三篇这个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ea5493508, createdName=ms2000001133177875, createdTime=Fri Sep 15 16:33:26 CST 2023, time=2023-09-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1235642, encodeId=410112356422a, content=with editor半个月了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cee66444803, createdName=ms6000000225875390, createdTime=Sat Jul 30 15:03:21 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582558, encodeId=8dca58255853, content=with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, beContent=imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=880d2050661, createdName=NAOHOO, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利 兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下 http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578006, encodeId=80e45e80068d, content=小修回来，很有希望imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！, beContent=imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0b61550754, createdName=imp_winner01072, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=)]

2020-10-29 傲娇的小马尾

审稿速度:3.0 | 投稿命中率:50.0
经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下

126 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=895544, encodeId=5eea895544d8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80cf2053027, createdName=傲娇的小马尾, createdTime=Thu Oct 29 23:45:50 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215141, encodeId=5f69121514112, content=4.21投稿，4.27还在submitted to journal的状态，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbd32341984, createdName=122921ecm60(暂无昵称), createdTime=Wed Apr 27 21:45:28 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161347, encodeId=d1ad216134ea4, content=投稿命中率:25.0 经验分享：with editor时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Sat Oct 07 15:07:56 CST 2023, time=2023-10-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1235154, encodeId=8f7b12351542a, content=2022.7.14 投稿 7.18 With editor 7.20 开始Under Review 7.25两个审稿人接收审稿 保佑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=小田田19921106, createdTime=Wed Jul 27 21:31:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248959, encodeId=5e8e124895971, content=with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Wed Sep 14 21:55:23 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157856, encodeId=0391215e85664, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：衰老;神经退行性疾病 经验分享：6.9投，8.27一审小修，9.6投回，9.9收。我们实验室中三篇这个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ea5493508, createdName=ms2000001133177875, createdTime=Fri Sep 15 16:33:26 CST 2023, time=2023-09-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1235642, encodeId=410112356422a, content=with editor半个月了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cee66444803, createdName=ms6000000225875390, createdTime=Sat Jul 30 15:03:21 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582558, encodeId=8dca58255853, content=with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, beContent=imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=880d2050661, createdName=NAOHOO, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利 兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下 http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578006, encodeId=80e45e80068d, content=小修回来，很有希望imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！, beContent=imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0b61550754, createdName=imp_winner01072, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=)]

2022-04-27 122921ecm60(暂无昵称)

4.21投稿，4.27还在submitted to journal的状态，感觉不妙

48 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=895544, encodeId=5eea895544d8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80cf2053027, createdName=傲娇的小马尾, createdTime=Thu Oct 29 23:45:50 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215141, encodeId=5f69121514112, content=4.21投稿，4.27还在submitted to journal的状态，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbd32341984, createdName=122921ecm60(暂无昵称), createdTime=Wed Apr 27 21:45:28 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161347, encodeId=d1ad216134ea4, content=投稿命中率:25.0 经验分享：with editor时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Sat Oct 07 15:07:56 CST 2023, time=2023-10-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1235154, encodeId=8f7b12351542a, content=2022.7.14 投稿 7.18 With editor 7.20 开始Under Review 7.25两个审稿人接收审稿 保佑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=小田田19921106, createdTime=Wed Jul 27 21:31:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248959, encodeId=5e8e124895971, content=with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Wed Sep 14 21:55:23 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157856, encodeId=0391215e85664, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：衰老;神经退行性疾病 经验分享：6.9投，8.27一审小修，9.6投回，9.9收。我们实验室中三篇这个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ea5493508, createdName=ms2000001133177875, createdTime=Fri Sep 15 16:33:26 CST 2023, time=2023-09-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1235642, encodeId=410112356422a, content=with editor半个月了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cee66444803, createdName=ms6000000225875390, createdTime=Sat Jul 30 15:03:21 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582558, encodeId=8dca58255853, content=with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, beContent=imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=880d2050661, createdName=NAOHOO, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利 兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下 http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578006, encodeId=80e45e80068d, content=小修回来，很有希望imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！, beContent=imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0b61550754, createdName=imp_winner01072, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=)]

2023-10-07 snowboy 来自云南省

投稿命中率:25.0
经验分享：with editor时间比较长

31 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=895544, encodeId=5eea895544d8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80cf2053027, createdName=傲娇的小马尾, createdTime=Thu Oct 29 23:45:50 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215141, encodeId=5f69121514112, content=4.21投稿，4.27还在submitted to journal的状态，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbd32341984, createdName=122921ecm60(暂无昵称), createdTime=Wed Apr 27 21:45:28 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161347, encodeId=d1ad216134ea4, content=投稿命中率:25.0 经验分享：with editor时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Sat Oct 07 15:07:56 CST 2023, time=2023-10-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1235154, encodeId=8f7b12351542a, content=2022.7.14 投稿 7.18 With editor 7.20 开始Under Review 7.25两个审稿人接收审稿 保佑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=小田田19921106, createdTime=Wed Jul 27 21:31:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248959, encodeId=5e8e124895971, content=with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Wed Sep 14 21:55:23 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157856, encodeId=0391215e85664, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：衰老;神经退行性疾病 经验分享：6.9投，8.27一审小修，9.6投回，9.9收。我们实验室中三篇这个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ea5493508, createdName=ms2000001133177875, createdTime=Fri Sep 15 16:33:26 CST 2023, time=2023-09-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1235642, encodeId=410112356422a, content=with editor半个月了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cee66444803, createdName=ms6000000225875390, createdTime=Sat Jul 30 15:03:21 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582558, encodeId=8dca58255853, content=with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, beContent=imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=880d2050661, createdName=NAOHOO, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利 兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下 http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578006, encodeId=80e45e80068d, content=小修回来，很有希望imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！, beContent=imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0b61550754, createdName=imp_winner01072, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=)]

2022-07-27 小田田19921106

2022.7.14 投稿 7.18 With editor 7.20 开始Under Review 7.25两个审稿人接收审稿
保佑

49 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=895544, encodeId=5eea895544d8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80cf2053027, createdName=傲娇的小马尾, createdTime=Thu Oct 29 23:45:50 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215141, encodeId=5f69121514112, content=4.21投稿，4.27还在submitted to journal的状态，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbd32341984, createdName=122921ecm60(暂无昵称), createdTime=Wed Apr 27 21:45:28 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161347, encodeId=d1ad216134ea4, content=投稿命中率:25.0 经验分享：with editor时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Sat Oct 07 15:07:56 CST 2023, time=2023-10-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1235154, encodeId=8f7b12351542a, content=2022.7.14 投稿 7.18 With editor 7.20 开始Under Review 7.25两个审稿人接收审稿 保佑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=小田田19921106, createdTime=Wed Jul 27 21:31:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248959, encodeId=5e8e124895971, content=with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Wed Sep 14 21:55:23 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157856, encodeId=0391215e85664, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：衰老;神经退行性疾病 经验分享：6.9投，8.27一审小修，9.6投回，9.9收。我们实验室中三篇这个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ea5493508, createdName=ms2000001133177875, createdTime=Fri Sep 15 16:33:26 CST 2023, time=2023-09-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1235642, encodeId=410112356422a, content=with editor半个月了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cee66444803, createdName=ms6000000225875390, createdTime=Sat Jul 30 15:03:21 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582558, encodeId=8dca58255853, content=with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, beContent=imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=880d2050661, createdName=NAOHOO, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利 兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下 http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578006, encodeId=80e45e80068d, content=小修回来，很有希望imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！, beContent=imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0b61550754, createdName=imp_winner01072, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=)]

2022-09-14 ms3000001949605315

with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉

54 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=895544, encodeId=5eea895544d8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80cf2053027, createdName=傲娇的小马尾, createdTime=Thu Oct 29 23:45:50 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215141, encodeId=5f69121514112, content=4.21投稿，4.27还在submitted to journal的状态，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbd32341984, createdName=122921ecm60(暂无昵称), createdTime=Wed Apr 27 21:45:28 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161347, encodeId=d1ad216134ea4, content=投稿命中率:25.0 经验分享：with editor时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Sat Oct 07 15:07:56 CST 2023, time=2023-10-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1235154, encodeId=8f7b12351542a, content=2022.7.14 投稿 7.18 With editor 7.20 开始Under Review 7.25两个审稿人接收审稿 保佑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=小田田19921106, createdTime=Wed Jul 27 21:31:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248959, encodeId=5e8e124895971, content=with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Wed Sep 14 21:55:23 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157856, encodeId=0391215e85664, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：衰老;神经退行性疾病 经验分享：6.9投，8.27一审小修，9.6投回，9.9收。我们实验室中三篇这个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ea5493508, createdName=ms2000001133177875, createdTime=Fri Sep 15 16:33:26 CST 2023, time=2023-09-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1235642, encodeId=410112356422a, content=with editor半个月了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cee66444803, createdName=ms6000000225875390, createdTime=Sat Jul 30 15:03:21 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582558, encodeId=8dca58255853, content=with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, beContent=imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=880d2050661, createdName=NAOHOO, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利 兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下 http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578006, encodeId=80e45e80068d, content=小修回来，很有希望imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！, beContent=imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0b61550754, createdName=imp_winner01072, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=)]

2023-09-15 ms2000001133177875 来自北京

审稿速度:3.0 | 投稿命中率:95.0
偏重的研究方向：衰老;神经退行性疾病
经验分享：6.9投，8.27一审小修，9.6投回，9.9收。我们实验室中三篇这个

35 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=895544, encodeId=5eea895544d8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80cf2053027, createdName=傲娇的小马尾, createdTime=Thu Oct 29 23:45:50 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215141, encodeId=5f69121514112, content=4.21投稿，4.27还在submitted to journal的状态，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbd32341984, createdName=122921ecm60(暂无昵称), createdTime=Wed Apr 27 21:45:28 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161347, encodeId=d1ad216134ea4, content=投稿命中率:25.0 经验分享：with editor时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Sat Oct 07 15:07:56 CST 2023, time=2023-10-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1235154, encodeId=8f7b12351542a, content=2022.7.14 投稿 7.18 With editor 7.20 开始Under Review 7.25两个审稿人接收审稿 保佑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=小田田19921106, createdTime=Wed Jul 27 21:31:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248959, encodeId=5e8e124895971, content=with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Wed Sep 14 21:55:23 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157856, encodeId=0391215e85664, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：衰老;神经退行性疾病 经验分享：6.9投，8.27一审小修，9.6投回，9.9收。我们实验室中三篇这个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ea5493508, createdName=ms2000001133177875, createdTime=Fri Sep 15 16:33:26 CST 2023, time=2023-09-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1235642, encodeId=410112356422a, content=with editor半个月了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cee66444803, createdName=ms6000000225875390, createdTime=Sat Jul 30 15:03:21 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582558, encodeId=8dca58255853, content=with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, beContent=imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=880d2050661, createdName=NAOHOO, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利 兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下 http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578006, encodeId=80e45e80068d, content=小修回来，很有希望imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！, beContent=imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0b61550754, createdName=imp_winner01072, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=)]

2022-07-30 ms6000000225875390

with editor半个月了正常吗

45 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=895544, encodeId=5eea895544d8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80cf2053027, createdName=傲娇的小马尾, createdTime=Thu Oct 29 23:45:50 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215141, encodeId=5f69121514112, content=4.21投稿，4.27还在submitted to journal的状态，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbd32341984, createdName=122921ecm60(暂无昵称), createdTime=Wed Apr 27 21:45:28 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161347, encodeId=d1ad216134ea4, content=投稿命中率:25.0 经验分享：with editor时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Sat Oct 07 15:07:56 CST 2023, time=2023-10-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1235154, encodeId=8f7b12351542a, content=2022.7.14 投稿 7.18 With editor 7.20 开始Under Review 7.25两个审稿人接收审稿 保佑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=小田田19921106, createdTime=Wed Jul 27 21:31:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248959, encodeId=5e8e124895971, content=with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Wed Sep 14 21:55:23 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157856, encodeId=0391215e85664, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：衰老;神经退行性疾病 经验分享：6.9投，8.27一审小修，9.6投回，9.9收。我们实验室中三篇这个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ea5493508, createdName=ms2000001133177875, createdTime=Fri Sep 15 16:33:26 CST 2023, time=2023-09-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1235642, encodeId=410112356422a, content=with editor半个月了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cee66444803, createdName=ms6000000225875390, createdTime=Sat Jul 30 15:03:21 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582558, encodeId=8dca58255853, content=with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, beContent=imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=880d2050661, createdName=NAOHOO, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利 兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下 http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578006, encodeId=80e45e80068d, content=小修回来，很有希望imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！, beContent=imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0b61550754, createdName=imp_winner01072, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=)]

2020-01-02 NAOHOO

with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表:
今天终于接收了，mark

imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark

107 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=895544, encodeId=5eea895544d8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80cf2053027, createdName=傲娇的小马尾, createdTime=Thu Oct 29 23:45:50 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215141, encodeId=5f69121514112, content=4.21投稿，4.27还在submitted to journal的状态，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbd32341984, createdName=122921ecm60(暂无昵称), createdTime=Wed Apr 27 21:45:28 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161347, encodeId=d1ad216134ea4, content=投稿命中率:25.0 经验分享：with editor时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Sat Oct 07 15:07:56 CST 2023, time=2023-10-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1235154, encodeId=8f7b12351542a, content=2022.7.14 投稿 7.18 With editor 7.20 开始Under Review 7.25两个审稿人接收审稿 保佑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=小田田19921106, createdTime=Wed Jul 27 21:31:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248959, encodeId=5e8e124895971, content=with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Wed Sep 14 21:55:23 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157856, encodeId=0391215e85664, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：衰老;神经退行性疾病 经验分享：6.9投，8.27一审小修，9.6投回，9.9收。我们实验室中三篇这个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ea5493508, createdName=ms2000001133177875, createdTime=Fri Sep 15 16:33:26 CST 2023, time=2023-09-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1235642, encodeId=410112356422a, content=with editor半个月了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cee66444803, createdName=ms6000000225875390, createdTime=Sat Jul 30 15:03:21 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582558, encodeId=8dca58255853, content=with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, beContent=imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=880d2050661, createdName=NAOHOO, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利 兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下 http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578006, encodeId=80e45e80068d, content=小修回来，很有希望imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！, beContent=imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0b61550754, createdName=imp_winner01072, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=)]

2021-05-21 da-xiang

审稿速度:3.0 | 投稿命中率:25.0
经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利
兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下
http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413

83 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=895544, encodeId=5eea895544d8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80cf2053027, createdName=傲娇的小马尾, createdTime=Thu Oct 29 23:45:50 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215141, encodeId=5f69121514112, content=4.21投稿，4.27还在submitted to journal的状态，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbd32341984, createdName=122921ecm60(暂无昵称), createdTime=Wed Apr 27 21:45:28 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161347, encodeId=d1ad216134ea4, content=投稿命中率:25.0 经验分享：with editor时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Sat Oct 07 15:07:56 CST 2023, time=2023-10-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1235154, encodeId=8f7b12351542a, content=2022.7.14 投稿 7.18 With editor 7.20 开始Under Review 7.25两个审稿人接收审稿 保佑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=小田田19921106, createdTime=Wed Jul 27 21:31:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248959, encodeId=5e8e124895971, content=with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Wed Sep 14 21:55:23 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157856, encodeId=0391215e85664, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：衰老;神经退行性疾病 经验分享：6.9投，8.27一审小修，9.6投回，9.9收。我们实验室中三篇这个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ea5493508, createdName=ms2000001133177875, createdTime=Fri Sep 15 16:33:26 CST 2023, time=2023-09-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1235642, encodeId=410112356422a, content=with editor半个月了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cee66444803, createdName=ms6000000225875390, createdTime=Sat Jul 30 15:03:21 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582558, encodeId=8dca58255853, content=with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, beContent=imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=880d2050661, createdName=NAOHOO, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利 兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下 http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578006, encodeId=80e45e80068d, content=小修回来，很有希望imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！, beContent=imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0b61550754, createdName=imp_winner01072, createdTime=Wed Oct 16 00:00:00 CST 2019, time=2019-10-16, status=1, ipAttribution=)]

2019-10-16 imp_winner01072

小修回来，很有希望imp_winner01072 2019-09-24 00:00:00 发表:
一篇文章大修中。。。希望好运！！！

imp_winner01072 2019-09-24 00:00:00 发表: 一篇文章大修中。。。希望好运！！！

136 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务